USP to Assemble Stakeholders for Three-Part Medicines Supply Chain Series

Discussions will revolve around fortifying the pharma supply chain

United States Pharmacopeia (USP), an independent, scientific nonprofit organization, will be hosting a three-part series of conversations with key stakeholders that are working toward strengthening the medicines supply chain.

The series will bring together USP Convention members representing patient, provider, scientific, regulator and industry viewpoints to assess points along the pharma supply chain.

The first conversation in the series, "Reducing Barriers to Adoption of Advanced Manufacturing Technology," will feature Convention member representatives and stakeholders from the Association for Accessible Medicines, the National Institute of Standards and Technology and Research!America, along with USP leaders. Taking place on Feb. 25, 2022, the event will focus on the role of advanced manufacturing technology in maintaining the quality of medicines throughout the supply chain and approaches for reducing barriers to its adoption.

The remaining two conversations on preparing the medicines supply chain for resilience ahead of future disruptions, and successes and strategies for multinational cooperation will take place in March and May, respectively.

"In recent months, supply chain challenges have been the subject of much media coverage and political dialogue," notes Anthony Lakavage, JD, senior vice president, global external affairs and secretary of the USP Convention. "While many of the challenges aren't new, COVID-19 has added urgency and an opportunity to strengthen the resilience of the pharmaceutical supply chain. The supply chain for medicines is complex and spans the globe—no one government, organization, or company has all the solutions or capacity to strengthen the supply chain alone; perspectives, input, expertise and resources from many sectors are needed.”